X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: Part B and biosimilars, part 2

By Kelsey Lang  |    November 30, 2015
Earlier this month, Medicare Monday covered the Center for Medicare & Medicaid Services (CMS) final rule on reimbursement for biosimilars and the implications of using a single billing code to...   Read More

5 ways your insurer may prevent you from getting your medicine

By Allyson Funk  |    November 30, 2015
We’ve talked about the 5 things to consider when choosing your health coverage and the 5 questions to ask about your prescription medicine coverage, but it is also important to know the barriers...   Read More

ICYMI: Physicians want better information sharing with biopharmaceutical companies

By Mit Spears  |    November 23, 2015
The issue and debate around communications with health care professionals is at its very essence, a conversation about ensuring physicians have the best possible data to effectively treat...   Read More

Bringing innovation to light during Lung Cancer Awareness Month

By Hannah Mooney  |    November 23, 2015
Lung Cancer Awareness Month is an opportunity to celebrate the stories of survivors, raise awareness about the leading cause of cancer death and continue the search for innovative new treatments...   Read More

Medicare Monday: The importance of shopping around for your Part D plan this Thanksgiving

By Ashley Flint  |    November 23, 2015
We’ve spent some time talking about the importance of shopping around during Part D open enrollment, which is currently underway until December 7th, 2015. Existing Part D plan coverage and...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    November 20, 2015
Value of Medicine: Insurers continue to attack medicines and make it difficult for patients to access the drugs prescribed by their doctors. One patient shares his story about the difficulties...   Read More

“Drug of the week”: one patient’s story

By Pete Martinez  |    November 20, 2015
Insurers’ attacks on medicines often fail to account for the value of a medicine brings to society, the health care system and individual patients. This is exactly what the nation’s health...   Read More

340B Spotlight: New study raises questions about whether non-profit hospitals are meeting charity care requirements in Affordable Care Act

By Karyn Schwartz  |    November 19, 2015
New data published in The New England Journal of Medicine shows that many non-profit hospitals are not meeting charity care requirements in the Affordable Care Act. These requirements were...   Read More

6 things to know before the HHS forum

By Robert Zirkelbach  |    November 19, 2015
Tomorrow, the Department of Health and Human Services (HHS) will host a forum on pharmaceutical innovation, access, affordability and better health. We welcome the opportunity to discuss how we...   Read More

PhRMA Foundation celebrates 50 years launching scientific careers

By Eileen Cannon  |    November 18, 2015
This November, we are pleased to be celebrating the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation’s 50th anniversary, commemorating five decades of jumpstarting the...   Read More

New Video: Clinical trials serve as engine for local economic growth

By Priscilla VanderVeer  |    November 18, 2015
Without clinical trials, new medicines could not be approved and made available to the patients who need them. But beyond connecting patients to new treatments and potential cures for some of the...   Read More

Impact of deductibles in health plans

By Rebecca Davison  |    November 18, 2015
We’ve seen reports on the use of high deductibles that include prescription drugs in health insurance exchange plans and the burden they put on patients. A recent IMS Health report, Emergence and...   Read More

ICYMI – IMS Institute – Branded net medicine price increases “lowest in past five years”

By Holly Campbell  |    November 17, 2015
In case you missed it, a new IMS Institute health care brief found that net price increases in 2014 for branded medicines was the “lowest in the past five years” after accounting for discounts,...   Read More

Despite rhetoric, new data shows medicines are not primary driver of premium increases

By Karyn Schwartz  |    November 17, 2015
Despite claims from insurers about the impact of medicine costs on premium increases, their own data indicates otherwise.  In fact, just $3.29 of the average $25.26 increase in monthly premiums in...   Read More

Medicare Monday: Medicare Part B and biosimilars

By Andrew Powaleny  |    November 16, 2015
With the first U.S. biosimilar approved in March of 2015, the pathway created by the Biologics Price Competition and Innovation Act to bring biosimilars to market for U.S. patients has become a...   Read More

BMJ clinical trial report misleading

By Jocelyn Ulrich  |    November 16, 2015
Biopharmaceutical companies are committed to enhancing the transparency of their research in a responsible manner. To demonstrate their commitment, in July 2013 PhRMA joined with the European...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    November 13, 2015
Access Problems in Exchanges: The New York Times drew attention to complaints about health insurance exchange plans with limited access to doctors and hospitals. New requirements would require...   Read More

The Pacira Case Study: Patients are better served when health care professionals have the most accurate and up-to-date medical information

By Mit Spears  |    November 13, 2015
Patients are better served when health care professionals have the most accurate and up-to-date medical information. This is true for data and information regarding FDA-approved uses and medically...   Read More

ICYMI: Regulators urge broader health networks

By Allyson Funk  |    November 12, 2015
In case you missed it, a recent story in The New York Times discussed new efforts to address complaints about limited access to doctors and hospitals in certain health insurance exchange plans,...   Read More

5 Questions to ask about your prescription medicine coverage

By Allyson Funk  |    November 11, 2015
Navigating health coverage can be complicated. Last week we covered 5 things to consider when choosing a plan. But how can you find out if the medicines you and your family need are covered? Here...   Read More

Ensuring personalized medicines reach patients

By Andrew Powaleny  |    November 10, 2015
Personalized medicine is changing the health care landscape for patients by bringing new and innovative treatments to the market. Among the many benefits of personalized medicine, include...   Read More

A shared commitment to value

By Randy Burkholder  |    November 9, 2015
Last week, the New England Journal of Medicine published a perspective from PhRMA’s Dr. Bill Chin alongside a counterpoint by Dr. Peter Bach, and I was struck by the extent to which both pieces...   Read More

Medicare Monday: Access to medicines for veterans

By Allyson Funk  |    November 9, 2015
This week on Veterans Day we celebrate and salute the men and women who have served our country. Our veterans put their lives on the line for our country and ensuring they have access to medicines...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    November 6, 2015
The Partnership for Prescription Assistance: Since 2005, the PPA has helped nearly 9.5 million patients get access to public and private assistance programs. Learn how the PPA connects uninsured...   Read More

The Partnership for Prescription Assistance: A history of caring

By Ieva M. Augstums  |    November 4, 2015
America is a country of problem solvers, innovators and dreamers. In April 2005, professionals on the front lines of health care at America’s biopharmaceutical research companies, created the...   Read More

340B Spotlight: ICYMI – New study on hospital-physician practice consolidation

By Rachel Licata  |    November 3, 2015
In case you missed it, a recent study in JAMA Internal Medicine, “Association of Financial Integration Between Physicians and Hospitals with Commercial Health Care Prices,” looked at the spending...   Read More

5 Things to consider when choosing your health coverage

By Allyson Funk  |    November 3, 2015
Choosing a health insurance plan can feel like an overwhelming task and making sure you understand your coverage and out-of-pocket costs is important to ensure you can access the services and...   Read More

Strengthening IP would significantly boost India’s economy

By Mark Grayson  |    November 2, 2015
On the heels of the October 28 U.S.-India Trade Policy Forum, PhRMA Chairman and Merck Chief Executive Officer Ken Frazier traveled to New Delhi this week for meetings with top Indian government...   Read More

Medicare Monday: New hepatitis C treatments in Medicare

By Ashley Flint  |    November 2, 2015
America’s innovative biopharmaceutical companies are committed to researching and developing treatments that help patients live longer, healthier lives. In recent years new treatments for...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates